Equities research analysts predict that Humana Inc. (NYSE:HUM) will report sales of $13.29 billion for the current quarter, according to Zacks Investment Research. Seven analysts have provided estimates for Humana’s earnings. The lowest sales estimate is $13.11 billion and the highest is $13.49 billion. Humana posted sales of $13.69 billion during the same quarter last year, which suggests a negative year over year growth rate of 2.9%. The business is scheduled to announce its next earnings results on Friday, November 3rd.
On average, analysts expect that Humana will report full-year sales of $13.29 billion for the current year, with estimates ranging from $52.60 billion to $54.10 billion. For the next year, analysts expect that the company will report sales of $56.62 billion per share, with estimates ranging from $54.59 billion to $58.34 billion. Zacks’ sales calculations are a mean average based on a survey of sell-side research firms that that provide coverage for Humana.
Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share for the quarter, topping the consensus estimate of $3.08 by $0.41. Humana had a net margin of 3.37% and a return on equity of 15.85%. The firm had revenue of $13.53 billion for the quarter, compared to analysts’ expectations of $13.61 billion. During the same period in the previous year, the company posted $2.30 EPS.
Several equities research analysts have recently issued reports on HUM shares. ValuEngine raised shares of Humana from a “hold” rating to a “buy” rating in a research report on Friday, September 1st. UBS AG reissued a “neutral” rating and set a $250.00 price objective (up previously from $237.00) on shares of Humana in a research report on Wednesday, August 9th. BidaskClub raised shares of Humana from a “sell” rating to a “hold” rating in a research report on Thursday, August 10th. Cantor Fitzgerald reissued a “neutral” rating and set a $223.00 price objective (up previously from $200.00) on shares of Humana in a research report on Thursday, August 3rd. Finally, Morgan Stanley increased their price objective on shares of Humana from $269.00 to $276.00 and gave the stock an “overweight” rating in a research report on Thursday, August 17th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have given a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $244.35.
In other news, CEO Bruce D. Broussard sold 12,000 shares of the firm’s stock in a transaction dated Friday, August 11th. The shares were sold at an average price of $251.88, for a total transaction of $3,022,560.00. Following the completion of the sale, the chief executive officer now owns 80,086 shares in the company, valued at approximately $20,172,061.68. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Elizabeth D. Bierbower sold 9,786 shares of the firm’s stock in a transaction dated Friday, September 1st. The stock was sold at an average price of $259.00, for a total transaction of $2,534,574.00. Following the sale, the insider now owns 18,042 shares of the company’s stock, valued at approximately $4,672,878. The disclosure for this sale can be found here. In the last three months, insiders sold 60,566 shares of company stock valued at $15,326,746. Insiders own 0.80% of the company’s stock.
Several hedge funds and other institutional investors have recently bought and sold shares of the company. BlackRock Inc. lifted its stake in shares of Humana by 2,281.7% during the 1st quarter. BlackRock Inc. now owns 12,387,144 shares of the insurance provider’s stock worth $2,553,487,000 after buying an additional 11,867,056 shares during the last quarter. Vanguard Group Inc. lifted its stake in shares of Humana by 1.6% during the 2nd quarter. Vanguard Group Inc. now owns 9,892,635 shares of the insurance provider’s stock worth $2,380,366,000 after buying an additional 157,868 shares during the last quarter. FMR LLC lifted its stake in shares of Humana by 29.3% during the 2nd quarter. FMR LLC now owns 6,530,063 shares of the insurance provider’s stock worth $1,571,264,000 after buying an additional 1,479,210 shares during the last quarter. State Street Corp lifted its stake in shares of Humana by 1.4% during the 1st quarter. State Street Corp now owns 6,274,811 shares of the insurance provider’s stock worth $1,293,487,000 after buying an additional 84,716 shares during the last quarter. Finally, Capital Research Global Investors lifted its stake in shares of Humana by 9.7% during the 2nd quarter. Capital Research Global Investors now owns 3,907,333 shares of the insurance provider’s stock worth $940,182,000 after buying an additional 346,069 shares during the last quarter. Institutional investors own 95.14% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “Brokerages Anticipate Humana Inc. (HUM) Will Announce Quarterly Sales of $13.29 Billion” was originally published by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The original version of this news story can be read at https://www.truebluetribune.com/2017/09/17/brokerages-anticipate-humana-inc-hum-will-announce-quarterly-sales-of-13-29-billion.html.
Humana (NYSE HUM) traded up 0.01% during trading on Friday, reaching $256.56. 837,622 shares of the company’s stock traded hands. The company has a market cap of $37.08 billion, a P/E ratio of 21.11 and a beta of 0.87. The firm’s 50 day moving average is $247.64 and its 200 day moving average is $229.85. Humana has a 12 month low of $163.50 and a 12 month high of $259.47.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Tuesday, August 29th will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.62%. The ex-dividend date is Thursday, September 28th. Humana’s dividend payout ratio (DPR) is presently 13.06%.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.